The Body Composition Analyzers Market is expected to reach USD 670.48 Million by 2030 at 8.10% CAGR during the forecast period 2022-2030.
Body Composition Analyzers Market Synopsis
The increasing obese population and the growing presence of metabolic disorders are set to drive the demand for body composition analyzers during the forecast period.
Body composition is a ratio of compounds such as water, fat mass, and muscle mass in the human body. Body composition analyzers are used to measure the ratio water, fat and muscles present in the body and to calculate their respective values at the point of the examination. These devices help in analyzing increased variations in the body structure for a specific period. The body composition analyzers have applications in the arena of medical research, sports, causal association research studies in the disciplines of nutrition, anthropology, epidemiology, etc.
Strategic mergers & acquisitions and new product launches are also projected to boost market growth with companies looking to strengthen their market positions, expand their product portfolios, and improves their brand images. Many companies are working in collaboration with the government and developing innovative and easy to use body composition analyzers to strengthen its position in the global body composition analyzers market. For instance, in October 2017, SELVAS Healthcare launched AI-based Body Composition Analyzer ACCUNIQ BC380 in the market. This product will help the company to capture the untapped segment.
The increasing number of weight loss clinics and the growing fitness industry are strongly influencing the growth of the Body Composition Analyzers Market and likely to provide favorable conditions for the growth of the market. Demand for body composition analyzers from clinics is significant, and in the future, it is expected to increase due to rising awareness about fitness.
Body Composition Analyzers Market Segmentation
By Product Type
Body Composition Aanalyzers Market Key Players
|Market Size||2030: USD 670.48 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Product Type and End-User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Bodysuit, Cosmed S.R.L, GE Healthcare, Inc., Hologic Inc., Beurer GmbH, Inbody Co. Ltd., Jawon Medical Co., Ltd, Maltron International Ltd., Omron Healthcare, Inc., Seca GmbH & Co. Kg., Tanita Corporation, AccuFitness, LLC, Others|
|Key Market Opportunities||
|Key Market Drivers||
The valuation of the global body composition analyzers market is estimated to reach USD 670.48 Million by 2030.
The global body composition analyzers market is projected to grow at approximately 8.10% CAGR during the forecast period (2022-2030).
Rising obese population and growing prevalence of metabolic disorders.
North America holds the largest share in the global body composition analyzers market, followed by Europe and the Asia Pacific, respectively.
GE Healthcare, Inc., Bodysuit Cosmed S.R.L, Hologic Inc., Jawon Medical Co., Ltd., Beurer GmbH Inbody Co. Ltd., Maltron International Ltd., Seca GmbH & Co. Kg., Omron Healthcare, Inc., and Tanita Corporation AccuFitness, LLC, are some of the major players operating in the body composition analyzers market.